Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

1561 Results

Resource Listings

Sample Forms, Policies, and Contracts

Sample Corporate Decision-Making Authority Matrix

This sample matrix shows levels of decision-making authority per type of decision, agreement or act involved. The matrix distinguishes between decision makers, alternate decision makers, or persons who must be consulted or must be informed.

Sample Forms, Policies, and Contracts

Sample Signature Authority Policy

This is a sample company policy setting out general guidance and dollar limitations to which management and employees may commit the Company, the level(s) of management by which certain categories of commitments must be approved, and general procedures for requesting and obtaining such approval.

Sample Forms, Policies, and Contracts

Form of Share Repurchase Resolutions

By Alston & Bird LLP

This is a sample board resolution approving the repurchase of a company's common stock and authorizing the company's officers to carry out the repurchase, under Delaware law (United States).

Sample Forms, Policies, and Contracts

LLC Operating Agreement for Virginia

This is a sample limited liability company (LLC) operating agreement for the state of Virginia - agreement between the company and the sole member of the LLC.

Articles

Top 10 Patent and Regulatory Things You Need to Know when Bringing a Biopharma Product to Canada

By Nancy Pei, Principal, Alice Tseng, Principal, Toronto Office and Daphne Lainson, Principal, Ottawa Office, Smart & Biggar LLP

Canada is an attractive market for pharmaceutical manufacturers. Most Canadian consumers have some form of drug coverage through government programs and/or private insurance. Below are ten patent and regulatory topics that in-house counsel need to know before bringing an innovative product to Canada.

Editor's note: This article was updated to reflect recent developments; the original version of this article was published on December 16, 2020.

Articles

Canada's New Linkage Litigation Scheme: A Comparison to Hatch-Waxman

By Nancy Pei, Partner, Smart & Biggar LLP and Brian Coggio, Fish & Richardson PC

The September 2017 amendments to the Patented Medicines (Notice of Compliance) Regulations introduced a new scheme for pharmaceutical patent linkage litigation in Canada. That scheme is now much closer to the United States' (US) Hatch-Waxman scheme, but with remaining key differences that are explained in this chart.

ACC